Authors and Disclosures
Niccolò Buetti1,2*, Alexis Tabah3–5, Ambre Loiodice6, Stéphane Ruckly6, Abdullah Tarik Aslan7, Giorgia Montrucchio8,9, Andrea Cortegiani10,11, Nese Saltoglu12, Bircan Kayaaslan13, Firdevs Aksoy14, Akova Murat15, Özlem Akdoğan16, Kemal Tolga Saracoglu17, Cem Erdogan18, Marc Leone19, Ricard Ferrer20, José-Artur Paiva21,22, Yoshiro Hayashi23, Mahesh Ramanan24–26, Andrew Conway Morris27–29, François Barbier30,31 and Jean-François Timsit2,32 and the Eurobact 2 study group
1Infection Control Program and WHO Collaborating Centre on Patient Safety, Geneva University Hospitals and Faculty of Medicine, Rue Gabrielle-Perret-Gentil 4, 1205 Geneva, Switzerland. 2INSERM, IAME, Université Paris-Cité, 75006 Paris, France. 3Intensive Care Unit, Redcliffe Hospital, Metro North Hospital and Health Services, Brisbane, QLD, Australia. 4Queensland University of Technology, Brisbane, QLD, Australia. 5Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia. 6ICURESEARCH, 26 rue Garibaldi, Fontaine, France. 7Department of Internal Medicine, Hacettepe University, Sihhiye, Ankara, Turkey. 8Department of Surgical Sciences, University of Turin, Turin, Italy. 9Department of Anaesthesia, Critical Care and Emergency, Città Della Salute e Della Scienza Hospital, Turin, Italy. 10Department of Surgical Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Palermo, Italy. 11Department of Anesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy. 12Department of Infectious Diseases and Clinical Microbiology, Istanbul University-Cerrahpasa, Istanbul, Turkey. 13Department of Infectious Diseases and Clinical Microbiology, Ankara City Hospital, Ankara Yıldırım Beyazıt University, Ankara, Turkey. 14Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University, Ortahisar, Turkey. 15Department of Infectious Diseases and Clinical Microbiology, Hacettepe University, Ankara, Turkey. 16Department of Infectious Diseases and Clinical Microbiology, Erol Olcok Research and Training Hospital, Hitit University, Çorum Merkez, Turkey. 17Department of Anesthesiology and Reanimation, Kartal Dr. Lütfi Kırdar City Hospital, Kartal, Turkey. 18Department of Anesthesiology and Reanimation, Medipol Mega Hospital, Bağcılar, Turkey. 19Department of Anesthesiology and Intensive Care Unit, Hospital Nord, Assistance Publique Hôpitaux Universitaires de Marseille, Aix Marseille University, Marseille, France. 20Intensive Care Department. SODIR Research Group, Vall d'Hebron Institute of Research VHIR, Hospital Universitari Vall d'Hebron, Barcelona, Spain. 21Intensive Care Medicine Department, Centro Hospitalar Universitário São João (CHUSJ), Porto, Portugal. 22Department of Medicine, Faculty of Medicine, University of Porto (FMUP), Porto, Portugal. 23Department of Intensive Care Medicine, Kameda General Hospital, Kamogawa, Japan. 24Caboolture and The Prince Charles Hospitals, Metro North Hospital and Health Services, Brisbane, QLD, Australia. 25Critical Care Division, The George Institute for Global Health, University of New South Wales, Sydney, Australia. 26School of Medicine, University of Queensland, St Lucia, Australia. 27Division of Anaesthesia, Department of Medicine, University of Cambridge, Cambridge, UK. 28Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK. 29JVF Intensive Care Unit, Addenbrooke's Hospital, Cambridge, UK. 30Médecine Intensive Réanimation, Centre Hospitalier Régional d'Orléans, Orléans, France. 31Centre d'Etude des Pathologies Respiratoires (CEPR), INSERM U1100, Université de Tours, Tours, France. 32Medical and Infectious Diseases Intensive Care Unit, AP-HP, Bichat-Claude Bernard University Hospital, 46 rue Henri Huchard, 75877 Paris Cedex, France.
NB, AT and JFT designed the study. All authors acquired the data. NB, AL, SR and JFT did the statistical analysis. NB, AL, SR, AT and JFT analyzed and interpreted the data. NB and JFT drafted the manuscript. All authors critically reviewed the manuscript and approved the final report. All authors read and approved the final manuscript.
The authors have disclosed that they do not have conflict of interest. Dr. Buetti received a grant from the Swiss National Science Foundation (Grant Number: P4P4PM_194449). Prof. Timsit received fees for lectures to 3M, MSD, Pfizer, and BioMérieux; he received research grants from Astellas, 3M, MSD, and Pfizer; and he participated to advisory boards of 3M, MSD, Bayer Pharma, Nabriva, and Pfizer. Dr. Barbier received consulting and lecture fees from MSD and BioMérieux. Prof. Cortegiani received fees for lectures from Gilead, MSD, Pfizer; and he participated to advisory boards of MSD, Gilead, Pfizer. Dr. Montrucchio received fees for lectures from Gilead, Pfizer, Thermofisher; and she participated to advisory boards of Gilead. Dr. Conway Morris sits on the scientific advisory board of Cambridge Infection Diagnostics. Prof. Akova received grants from Pfizer and Gilead, had lecture fees paid to the institution by Pfizer and Sanofi. Dr. Ramanan acknowledges support from the Metro North Hospital and Health Services Clinician-Researcher Fellowship. Dr. Conway Morris sits on the scientific advisory board of Cambridge Infection Diagnostics. Dr. Conway Morris is supported by a Clinician Scientist Fellowship from the Medical Research Council (MR/V006118/1). Prof. José-Artur Paiva received fees for consulting, advisory boards or lectures from MSD, Pfizer, Astra-Zeneca, Gilead, Jansen, Cepheid, AOP Orphan Pharmaceuticals.